Scribetech secures third consecutive award listing on NHS Commercial Solutions Framework with Textflow and Augnito
[London, 31 January 2023] – Scribetech has been re-appointed to the NHS Commercial Solutions Framework Agreement for the provision of digital dictation, speech/voice recognition, outsourced transcription and associated services in all four of the authority’s lots.
Scribetech (UK) Ltd has been re-awarded its third consecutive listing, since 2010, on the NHS Commercial Solutions Framework following the contracting authority’s comprehensive information gathering and tender evaluation process.
Scribetech will see its Textflow digital dictation solution and Augnito voice-AI speech recognition products offered to all NHS organisations.
The four lots under the NHS Commercial Solution framework agreement for which a product or services provider is invited to tender include: Products and/or Services Catalogue; In-house and Outsourced Digital Dictation Service Solution, Outsourced Transcription Service Solution, and Managed Service Solution.
Formed in 2007, and based in the South East of England, the NHS Commercial Solution Framework is a non-profit procurement shared services hub providing collaborative solutions and end-to-end services that combine data analytics and its dedicated category specialists’ in-depth knowledge of supply markets to address stakeholder needs. Categories include: corporate services, digital, estate and facilities, pharmacy, workforce and staffing, and clinical. These services are offered and provided across the NHS and the wider public sector, supporting acute, mental health, community, ambulance trusts, and commissioning organisations.
To date, NHS Commercial Solutions has saved in excess of £230 million for its customers, based on year one project savings alone.
Scribetech has long been recognised as a pioneering clinical transcription services and medical documentation company that has consistently ranked top on multiple NHS Framework contracts since 2005. “We are extremely pleased with the NHS Commercial Solutions award. It validates not only Scribetech’s vision and our digital dictation technology and voice-AI capabilities, but the ability to provide NHS organisations with cost-effective solutions that really do address many of the core issues that confront medical professionals on the healthcare frontline, such as improving efficiency and accuracy, as well as optimising clinical workflows, resources and budgets.” commented Shiraz Austin, Co-Founder of Augnito and Managing Director at Scribetech (UK) Ltd.
“Scribetech was founded to provide acutely accurate, efficient, cost-effective, outsourced and in-house services and technology to support NHS clinical transcription. Augnito was developed as a result of 20 years of hands-on-experience delivering such services. Combining our digital dictation, transcription and speech recognition voice-AI offering as an augmented clinical administration solution is where we believe NHS organisations will start to see their digital transformation garnering the positive results they critically need across all care departments” concluded Austin.
Notes to editors
For further information, interview opportunities or accompanying graphics please contact: [email protected]
About Scribetech Textflow and Augnito
Visit https://www.scribetech.co.uk/ for more details.